Scientific Evidence

Explore the supporting evidence and insights on CLiX® technology documented in scientific, peer reviewed & published papers.

American Society of Clinical Oncology (ASCO)

04/06/2023

A large scale evaluation of pulmonary nodule workup: A real-world study of over 150,000 patients in New York State. Clinithink's CLiX unlock was used to analyze 58 million patient documents from a NY state health information exchange and identify suitable candidates for further investigation or surgery.

Genome Medicine

16/03/2023

Rady Children’s Hospital in San Diego and the University of Utah used Clinithink's CLiX unlock solution to automate the prioritision of sick newborns for whole genome sequencing. The approach combined a clinical natural language processing (CNLP) workflow with a machine learning-based prioritisation tool named Mendelian Phenotype Search Engine (MPSE).

Genome Medicine

14/10/2021

A study published in Genome Medicine which documents how Clinithink’s patented CLiX technology can be used to simplify and speed up genome interpretation by integrating predictive methods with the growing knowledge of genetic diseases.

Int. Journal of Medical Informatics

01/09/2019

A study published in the International Journal of Medical Informatics which documents the role played by Clinithink’s patented clinical natural language processing platform in identifying patients with non-alcoholic fatty liver disease at risk for disease progression.

Science Translational Medicine

24/04/2019

A study published in Science Translational Medicine documents the role played by Clinithink’s patented clinical natural language processing platform in delivering genetic diagnoses to neonatal and pediatric intensive care physicians in record breaking time.